Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Net Income: 2019-2024

Historic Net Income for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to -$376.8 million.

  • Beam Therapeutics' Net Income fell 16.61% to -$112.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$421.8 million, marking a year-over-year decrease of 191.13%. This contributed to the annual value of -$376.8 million for FY2024, which is 184.25% down from last year.
  • Per Beam Therapeutics' latest filing, its Net Income stood at -$376.8 million for FY2024, which was down 184.25% from -$132.6 million recorded in FY2023.
  • In the past 5 years, Beam Therapeutics' Net Income ranged from a high of -$132.6 million in FY2023 and a low of -$376.8 million during FY2024.
  • For the 3-year period, Beam Therapeutics' Net Income averaged around -$257.7 million, with its median value being -$263.6 million (2022).
  • In the last 5 years, Beam Therapeutics' Net Income skyrocketed by 49.71% in 2023 and then plummeted by 184.25% in 2024.
  • Over the past 5 years, Beam Therapeutics' Net Income (Yearly) stood at -$194.6 million in 2020, then slumped by 90.47% to -$370.6 million in 2021, then rose by 28.88% to -$263.6 million in 2022, then skyrocketed by 49.71% to -$132.6 million in 2023, then slumped by 184.25% to -$376.8 million in 2024.